Inclusion Criteria:

• Any gender, aged 18-30 years, inclusive.
• Successful previous contact lens wearer
• Documented ongoing myopia progression (at least 0.50D over past 2 years)
• Refractive error meeting the following by cycloplegic autorefraction:
• Myopia -0.50D to -5.00D SER in both eyes
• Astigmatism (absolute value) ≤ 1.50 D in both eyes
• Anisometropia < 1.50 D SER.

Best-corrected distance visual acuity (BCDVA) in current correction as follows:

• 0.1 logMAR or better
• Interocular difference ≤ 0.1 log MAR

Exclusion Criteria:

• Current or previous use of pharmacologic or optical myopia control treatment within the past 2 years.
• Any ocular disease or abnormality affecting the cornea, lens, retina, iris, ciliary body, choroid, or sclera.
• History of manifest strabismus, amblyopia, or nystagmus.
• Previous eyelid, strabismus, intraocular, or refractive surgery. I- ntraocular pressure >26 mmHg.
• of premature birth (≥6 weeks before the due date).
• Neurological disorders, genetic syndromes, or other conditions that would interfere with completion of study procedures.
• Known allergy or hypersensitivity to fluorescein, proparacaine, or tropicamide.
• Conditions associated with degenerative myopia or abnormal ocular anatomy (e.g., Marfan syndrome, Stickler syndrome, retinopathy of prematurity, keratoconus, lenticonus, or spherophakia).
• Regular use of ocular medications, artificial tears, or wetting agents.
• Current use of systemic medications that may affect contact lens wear, tear film, pupil size, accommodation, electrophysiology, or refractive state.
• Diagnosis of or treatment for attention-deficit/hyperactivity disorder (ADHD) or a learning disability.
• Systemic disease that may affect visual function (e.g., diabetes mellitus).
• Ocular inflammation within 30 days before screening.
• Slit-lamp findings that contraindicate contact lens wear (e.g., corneal scars, corneal neovascularization, giant papillary conjunctivitis).
• Blepharospasm or other eyelid abnormalities that interfere with contact lens wear.
• Any severe ocular or systemic condition that, in the investigator's judgment, would interfere with study participation or follow-up.